Guidelines Addressing Use of Compounded Medications Released by the AAEP
American Association of Equine Practitioners
The Drug Compounding Task Force of the American Association of Equine Practitioners (AAEP) has released guidelines regarding the responsible use of compounded medications by veterinarians. The guidelines are the result of the associationís commitment to educating its members on this increasingly important topic within the animal health industry.
Issues addressed in the guidelines include the negative effects on efficacy that can result from using products not held to the governmentís standards for compounding as well as the appropriate use of bulk drugs in the preparation of compounded medications. To view a copy of the guidelines, click on the the "Resources" section of the AAEP Web site and select "Drug Compounding".
The AAEP is one of the first organizations to directly address the mounting ethical dilemmas and consequences related to illegal compounding. While drug compounding serves a very legitimate and important purpose in animal health, manufacturers must abide by federal regulations in order to create a high-quality, safe product and encourage a fair marketplace for animal health products.
The American Association of Equine Practitioners, headquartered in Lexington, Kentucky, was founded in 1954 as a non-profit organization dedicated to the health and welfare of the horse. Currently, the AAEP reaches more than 5 million horse owners through its over 8,000 members worldwide and is actively involved in ethics issues, practice management, research and continuing education in the equine veterinary profession and horse industry.